Menu
GeneBe

rs12947788

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000546.6(TP53):c.782+72C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0995 in 1,155,766 control chromosomes in the GnomAD database, including 7,796 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1035 hom., cov: 31)
Exomes 𝑓: 0.099 ( 6761 hom. )

Consequence

TP53
NM_000546.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.189
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-7674109-G-A is Benign according to our data. Variant chr17-7674109-G-A is described in ClinVar as [Benign]. Clinvar id is 1243351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-7674109-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TP53NM_000546.6 linkuse as main transcriptc.782+72C>T intron_variant ENST00000269305.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TP53ENST00000269305.9 linkuse as main transcriptc.782+72C>T intron_variant 1 NM_000546.6 P1P04637-1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15808
AN:
151834
Hom.:
1038
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.118
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.0709
Gnomad EAS
AF:
0.321
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.0516
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0803
Gnomad OTH
AF:
0.0909
GnomAD4 exome
AF:
0.0988
AC:
99213
AN:
1003814
Hom.:
6761
AF XY:
0.102
AC XY:
53065
AN XY:
518090
show subpopulations
Gnomad4 AFR exome
AF:
0.121
Gnomad4 AMR exome
AF:
0.147
Gnomad4 ASJ exome
AF:
0.0693
Gnomad4 EAS exome
AF:
0.301
Gnomad4 SAS exome
AF:
0.199
Gnomad4 FIN exome
AF:
0.0542
Gnomad4 NFE exome
AF:
0.0778
Gnomad4 OTH exome
AF:
0.0993
GnomAD4 genome
AF:
0.104
AC:
15824
AN:
151952
Hom.:
1035
Cov.:
31
AF XY:
0.106
AC XY:
7852
AN XY:
74276
show subpopulations
Gnomad4 AFR
AF:
0.119
Gnomad4 AMR
AF:
0.119
Gnomad4 ASJ
AF:
0.0709
Gnomad4 EAS
AF:
0.322
Gnomad4 SAS
AF:
0.197
Gnomad4 FIN
AF:
0.0516
Gnomad4 NFE
AF:
0.0803
Gnomad4 OTH
AF:
0.0938
Alfa
AF:
0.0939
Hom.:
91
Bravo
AF:
0.108
Asia WGS
AF:
0.238
AC:
824
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Li-Fraumeni syndrome 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJun 18, 2022- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJun 18, 2022- -
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitterclinical testingNational Health Laboratory Service, Universitas Academic Hospital and University of the Free StateApr 19, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
Cadd
Benign
6.2
Dann
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12947788; hg19: chr17-7577427; COSMIC: COSV52747994; COSMIC: COSV52747994; API